Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults
Clinical trial NCT03162614 · COMPLETED
Trial details
- NCT number
- NCT03162614
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-24
- Primary completion
- 2018-07-09
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.